RISK FACTORS OF VENOUS THROMBOEMBOLISM
IN SUDANESE PREGNANT WOMEN
Abdalhabib EK, Alfeel A, Ali EI, Ibrahim IK, Mobarki AA, Dobie G, Hamali HA, Saboor M,
*Corresponding Author: Dr. Muhammad Saboor, Department of Medical Laboratory Technology,
Faculty of Applied Medical Science, Jazan University, Jazan, Saudi Arabia. Tel.: +966-54-495-9029.
E-mail: msaboor@ jazanu.edu.sa
page: 49
|
|
REFERENCES
1. Croles FN, Nasserinejad K, Duvekot JJ, Kruip MJ,
Meijer K, Leebeek FW. Pregnancy, thrombophilia,
and the risk of a first venous thrombosis: systematic
review and bayesian meta-analysis. BMJ. 2017; 359:
j4452.
2. Seligsohn U, Lubetsky A. Medical progress: Genetic
susceptibility to venous thrombosis. N Engl J Med.
2001; 344(16): 1222-1231.
3. Roozbeh N, Banihashemi F, Mehraban M, Abdi F.
Potential role of Factor V Leiden mutation in adverse
pregnancy outcomes: An updated systematic review.
Biomed Res Ther. 2017; 4(12): 1832-1846.
4. Cernera G, Di Minno A, Amato F, Elce A, Liguori R,
Bruzzese D, et al. Molecular analysis of prothrom botic gene variants in venous thrombosis: A potential
role for sex and thrombotic localization. J Clin Med.
2020; 9(4): 1008.
5. Alsayegh F, Al-Jassar W, Wani S, Tahlak M, Albahar
A, Al Kharusi L, et al. Venous thromboembolism risk
and adequacy of prophylaxis in high risk pregnancy in
the Arabian Gulf. Curr Vasc Pharmacol. 2016; 14(4):
368-373.
6. James AH, Jamison MG, Brancazio LR, Myers ER.
Venous thromboembolism during pregnancy and the
postpartum period: incidence, risk factors, and mortality.
Am J Obstet Gynecol. 2006; 194(5): 1311-1315.
7. Ormesher L, Simcox L, Tower C, Greer IA. Management
of inherited thrombophilia in pregnancy.
Womens Health (Lond). 2016; 12(4): 433-441.
8. Pabinger I, Grafenhofer H, Kaider A, Kyrle PA, Quehenberger
P, Mannhalter C, et al. Risk of pregnancy-
associated recurrent venous thromboembolism
in women with a history of venous thrombosis. J
Thromb Haemost. 2005; 3(5): 949-954.
9. Bloomenthal D, von Dadelszen P, Liston R, Magee
L, Tsang P. The effect of factor V Leiden carriage on
maternal and fetal health. CMAJ. 2002; 167(1): 48-54.
10. Elzein HO, Saad AA, Yousif AA, Elamin E, Abdalhabib
EK, Elzaki SEG. Evaluation of Factor V Leiden
and prothrombin G20210A mutations in Sudanese
women with severe preeclampsia. Curr Res Transl
Med. 2020; 68(2): 77-80.
11. Hoffbrand AV, Moss PAH, Editors. Platelets, blood
coagulation and haemostasis. Hoffbrand’s Essential
Hematology, 7th ed. Chichester, West Sussex, UK:
John Wiley & Sons, Ltd. 2016: 135-144.
12. Kujovich JL. Factor v Leiden thrombophilia. Genet
Med. 2011; 13(1): 1-16.
13. Sultan AA, Tata LJ, West J, Fiaschi L, Fleming KM,
Nelson-Piercy C, et al. Risk factors for first venous
thromboembolism around pregnancy: A populationbased
cohort study from the United Kingdom. Blood.
2013; 121(19): 3953-3961.
14. Barillari G, Londero AP, Brenner B, Nauffal D,
Muñoz-Torrero JFS, Del Molino F, et al.; RIETE
Registry. Recurrence of venous thromboembolism in
patients with recent gestational deep vein thrombosis
or pulmonary embolism: Findings from the RIETE
Registry. Eur J Intern Med. 2016; 32: 53-59.
15. Knight M, UKOSS Antenatal pulmonary embolism:
Risk factors, management and outcomes. BJOG.
2008; 115(4): 453-461.
16. Gader AA, Haggaz AED, Adam I. Epidemiology of
deep venous thrombosis during pregnancy and puerperium
in Sudanese women. Vasc Health Risk Manag.
2009; 5(1): 85-87.
17. Babker AM, Ahmed IAM, Ismail M, Hassan FM,
Osman AL, Kandakurti PK, et al. Lack of association
between Factor V Leiden G1691A, prothrombin
G20210A, MTHFC677T mutations, and early recurrent
pregnancy loss in a group of Sudanese women.
Open Access Maced J Med Sci. [Internet]. 2020;
8(B): 553-557.
18. Nurk E, Tell GS, Refsum H, Ueland PM, Vollset SE.
Factor V Leiden, pregnancy complications and adverse
outcomes: The Hordaland Homocysteine Study.
QJM. 2006; 99(5): 289-298.
19. Elgari MM, Ibrahim NA, Muddathir ARM, Eltoom
FM, Ibrahim IM. Frequency of thrombophilic gene
mutations in patients with deep vein thrombosis and
in women with recurrent pregnancy loss. Open Life
Sci. 2017; 12(1): 162-166.
20. Ahmed NA, Adam I, Elzaki SEG, Awooda HA, Hamdan
HZ. Factor V Leiden G1691A and prothrombin
G20210A polymorphisms in Sudanese women
with pre-eclampsia, a case-control study. BMC Med
Genet. 2019; 20(1): 16-20.
21. Curigliano G, Mandalà M, Sbanotto A, Colleoni M,
Ferretti G, Bucciarelli P, et al. Factor V Leiden mutation
in patients with breast cancer with a central
venous catheter: Risk of deep vein thrombosis. Support
Cancer Ther [Internet]. 2006; 3(2): 98-102.
22. Monsuez J-J, Bouali H, Serve E, Boissonnas A, Alhenc-
Gelas M. Deep venous thrombosis associated
with Factor V Leiden, G20210A mutation, and protein
S deficiency. Am J Med. 2003; 114(5): 421-422.
23. Franchini M. Utility of testing for factor V Leiden.
Blood Transfus. 2012; 10(3): 257-259.
24. Farajzadeh M, Bargahi N, Poursadegh Zonouzi A,
Farajzadeh D, Pouladi N. Polymorphisms in thrombophilic
genes are associated with deep venous thromboembolism
in an Iranian population. Meta Gene
[Internet]. 2014; 2: 505–13.
25. Jusić-Karić A, Terzić R, Jerkić Z, Avdić A, Podanin
M. Frequency and association of 1691 (G>A) FVL,
20210 (G>A) PT and 677 (C>T) MTHFR with deep
vein thrombosis in the population of Bosnia and Herzegovina.
Balkan J Med Genet. 2016; 19(1): 43-49.
|
|
|
|
 |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
|
